HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adorjan Aszalos Selected Research

Platinum

9/2008SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adorjan Aszalos Research Topics

Disease

7Neoplasms (Cancer)
11/2008 - 02/2002
3Carcinoma (Carcinomatosis)
11/2008 - 02/2004
2Breast Neoplasms (Breast Cancer)
01/2010 - 12/2008

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
11/2008 - 02/2004
4Cisplatin (Platino)FDA LinkGeneric
11/2008 - 02/2004
3Proteins (Proteins, Gene)FDA Link
01/2010 - 02/2002
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2010 - 06/2003
1Multidrug Resistance-Associated ProteinsIBA
01/2010
1Subfamily B ATP Binding Cassette TransporterIBA
12/2008
1Cytochalasin BIBA
11/2008
1Sirtuin 1IBA
09/2008
1Deoxyglucose (2 Deoxy D glucose)IBA
09/2008
1PlatinumIBA
09/2008
1Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA
11/2005
1Ether (Diethyl Ether)IBA
11/2005
1Phosphotransferases (Kinase)IBA
02/2002

Therapy/Procedure

3Drug Therapy (Chemotherapy)
09/2008 - 02/2002
1Polypharmacy
10/2007